Search research articles
Contact Us
Filters
Showing results (231-240 of 1,048) with videos related to
Page
of 105
Sort By:
Journal of Hematotherapy
|
January 1, 1993
Does in vitro bone marrow purging improve the outcome after autologous bone marrow transplantation?
H M Lazarus, J M Rowe, A H Goldstone
Kidney International
|
August 1, 1984
Biocompatibility of dialysis membranes: effects of chronic complement activation
R M Hakim, D T Fearon, J M Lazarus
Bone Marrow Transplantation
|
July 4, 2021
Granulocyte transfusions in haematopoietic cell transplants and leukaemia: the phoenix or beating a dead horse?
Robert Peter Gale, Charles A Schiffer, Hillard M Lazarus
Transplantation
|
June 1, 1973
Hemodialysis duration and renal transplant survival
J M Lazarus, A G Birtch, C L Hampers
Best Practice & Research. Clinical Haematology
|
July 23, 2025
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface
Thomas R Spitzer, Hillard M Lazarus, Robert Peter Gale
Best Practice & Research. Clinical Haematology
|
December 13, 2023
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
Robert Peter Gale, Mei-Jie Zhang, Hillard M Lazarus
Survey of Ophthalmology
|
November 1, 1989
Ocular complications of systemic cancer chemotherapy
P S Imperia, H M Lazarus, J H Lass
Seminars in Oncology
|
December 1, 1989
Infectious emergencies in oncology patients
H M Lazarus, R J Creger, S L Gerson
Leukemia
|
March 8, 2024
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy
R P Gale, G L Phillips, H M Lazarus
Bone Marrow Transplantation
|
November 29, 2020
New cancer therapies. Are haematopoietic cell transplants a dead duck?
Robert Peter Gale, Gordon L Phillips, Hillard M Lazarus
Page
of 105
Search research articles
Search
Showing results (231-240 of 1,048) with videos related to
Sort By:
Page
of 105
Journal of Hematotherapy
|
January 1, 1993
Does in vitro bone marrow purging improve the outcome after autologous bone marrow transplantation?
H M Lazarus, J M Rowe, A H Goldstone
Kidney International
|
August 1, 1984
Biocompatibility of dialysis membranes: effects of chronic complement activation
R M Hakim, D T Fearon, J M Lazarus
Bone Marrow Transplantation
|
July 4, 2021
Granulocyte transfusions in haematopoietic cell transplants and leukaemia: the phoenix or beating a dead horse?
Robert Peter Gale, Charles A Schiffer, Hillard M Lazarus
Transplantation
|
June 1, 1973
Hemodialysis duration and renal transplant survival
J M Lazarus, A G Birtch, C L Hampers
Best Practice & Research. Clinical Haematology
|
July 23, 2025
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface
Thomas R Spitzer, Hillard M Lazarus, Robert Peter Gale
Best Practice & Research. Clinical Haematology
|
December 13, 2023
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
Robert Peter Gale, Mei-Jie Zhang, Hillard M Lazarus
Survey of Ophthalmology
|
November 1, 1989
Ocular complications of systemic cancer chemotherapy
P S Imperia, H M Lazarus, J H Lass
Seminars in Oncology
|
December 1, 1989
Infectious emergencies in oncology patients
H M Lazarus, R J Creger, S L Gerson
Leukemia
|
March 8, 2024
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy
R P Gale, G L Phillips, H M Lazarus
Bone Marrow Transplantation
|
November 29, 2020
New cancer therapies. Are haematopoietic cell transplants a dead duck?
Robert Peter Gale, Gordon L Phillips, Hillard M Lazarus
Page
of 105